VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
39 hedge funds and large institutions have $1.73M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 4 closing their positions.
Holders
39
Holders Change
+2
Holders Change %
+5.41%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
9
Closed
4
Calls
$532K
Puts
$1K
Net Calls
+$531K
Net Calls Change
-$139K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$108K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$42.6K |
| 3 |
3
Renaissance Technologies
New York
|
$39K |
| 4 |
4
Goldman Sachs
New York
|
$17.8K |
| 5 |
5
Morgan Stanley
New York
|
$37.6K |
